-
Merck's Keytruda Receives Priority Review for a Key Indication
Post on 4/8/20
-
Is Quest Diagnostics a Great Dividend Stock?
Post on 4/8/20
-
Children's Hospital of Philadelphia Physician-in-Chief Wins Leadership Award
Post on 4/19/20
-
ETHOS Health Communications Changes Name to PRECISIONscientia
Post on 4/7/20
-
MD1 Program Receives $25,000 Grant from Healthcare Foundation of New Jersey
Post on 4/7/20
-
The Rite Aid Foundation Donates $5MM to Address COVID-19 Pandemic
Post on 4/7/20
-
BrightView Provides Details of COVID-19 Response
Post on 4/7/20
-
Certara Launches COVID-19 Pharmacology Online Resource Center
Post on 4/7/20
-
Most Aggressive States Against the Coronavirus – WalletHub Study
Post on 4/7/20
-
Former Celgene Drug Earns a Key Approval for Bristol Myers Squibb
Post on 4/7/20
-
Immunomedics Halts Phase 3 Trial of Breast Cancer Drug Because of Compelling Efficacy
Post on 4/7/20
-
Inovio Pharmaceuticals Kicks Off Phase 1 Clinical Trial for Experimental COVID-19 Vaccine
Post on 4/7/20
-
Children's Hospital of Philadelphia and Philadelphia Housing Authority Partner
Post on 4/6/20
-
OPKO Health's BioReference Laboratories Partners with Hospitals Nationwide
Post on 4/6/20
-
HandsFree Health Provides Voice Technology Direct To Seniors At Home Through BeHomeSafe
Post on 4/6/20
-
Coronavirus Will Affect 68% of Easter Observers’ Spending Plans this Year – WalletHub
Post on 4/6/20
-
Fate Therapeutics Snags $3 Billion-Plus Deal With Johnson & Johnson
Post on 4/6/20
-
Should You Buy Inovio Pharmaceuticals During the Coronavirus Market Crash?
Post on 4/6/20
-
HealthVerity is Hiring to Keep Up With Biz Demands During the Pandemic
Post on 4/5/20
-
GNC Provides COVID-19 Related Business Update
Post on 4/4/20
-
The Kaplan Foundation Provides $10M Gift to Englewood Health
Post on 4/3/20
-
5 States Where Coronavirus Layoffs Are Hitting the Hardest
Post on 4/3/20
-
Pfizer, Merck, and Eli Lilly Will Pay Their Doctors to Get Back to Treating Patients During the COVID-19 Pandemic
Post on 4/3/20
-
Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19
Post on 4/3/20
-
Aclaris Therapeutics Secures $11M Term Loan Facility
Post on 4/1/20
Philadelphia
